Mechanisms of Resistance for CAR T Therapy – OncLive
OncLive |
Mechanisms of Resistance for CAR T Therapy
OncLive And so, when we've had patients who relapsed and still retained the CD19 antigen and they've generally had a loss of CAR T cells, they, in general, do not respond to a second infusion. And in those who don't respond, we've been able to show that they … |
